Recombinant Haemophilus influenzae Uncharacterized protein HI_0485.1 (HI_0485.1)

Shipped with Ice Packs
In Stock

Description

Expression and Purification

HI_0485.1 is produced in E. coli using recombinant DNA technology. The process involves:

  • Cloning: Gene insertion into an expression vector under a T7/lac promoter system .

  • Induction: Protein expression is induced using IPTG, followed by bacterial lysis and inclusion body isolation .

  • Refolding: Solubilization and refolding steps are critical due to the protein’s hydrophobic regions .

  • Purification: Affinity chromatography (Ni-NTA) leverages the His tag, followed by gel filtration for polishing .

ParameterCondition
YieldNot explicitly reported; typical for small proteins (~1–5 mg/L culture)
Buffer CompatibilityStable in Tris/PBS with trehalose as a cryoprotectant
StabilitySensitive to repeated freeze-thaw cycles; glycerol (5–50%) recommended for long-term storage

Functional Implications

HI_0485.1 is annotated as “uncharacterized,” but its homology to other H. influenzae proteins suggests potential roles in:

  • Virulence: Similar uncharacterized proteins in H. influenzae contribute to adhesion, invasion, or immune evasion . For example, the HMW1 adhesin facilitates epithelial cell invasion .

  • Membrane Dynamics: Hydrophobic residues may mediate interactions with host membranes or bacterial aggregates .

  • Enzymatic Activity: While no catalytic domains are identified, structural studies could reveal unforeseen functions .

Research Applications

This recombinant protein is primarily used in:

  • Antigenic Studies: Investigating immune responses to H. influenzae infections .

  • Structural Biology: X-ray crystallography or NMR to resolve its 3D conformation .

  • Functional Screens: Testing interactions with host proteins or small molecules .

Limitations and Future Directions

  • Unknown Function: HI_0485.1’s biological role remains unverified .

  • Aggregation Risks: Hydrophobicity may complicate solubility, necessitating optimized refolding protocols .

  • Clinical Relevance: Further studies could link HI_0485.1 to H. influenzae pathogenicity, aiding vaccine or therapeutic development .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag type, please inform us; we will prioritize its development.
Synonyms
HI_0485.1; Uncharacterized protein HI_0485.1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-124
Protein Length
full length protein
Species
Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
Target Names
HI_0485.1
Target Protein Sequence
MSRILSHAKKNYRKAIVIESLLLVVFYLLIYGWQRQSAVDFSYGFLSAFLPFCTFIFIIF YRKQNFSTKLTALYRAEAIKFILTMVFIIIAIKWLFVINFIAFFVGFLLALVLNNIIPLI LNKI
Uniprot No.

Target Background

Database Links
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is known about the structure and potential function of HI_0485.1?

HI_0485.1 is a 124-amino acid protein with the sequence "MSRILSHAKKNYRKAIVIESLLLVVFYLLIYGWQRQSAVDFSYGFLSAFLPFCTFIFIIFYRKQNFSTKLTALYRAEAIKFILTMVFIIIAIKWLFVINFIAFFVGFLLALVLNNIIPLILNKI" . Structural analysis suggests it contains multiple hydrophobic regions resembling transmembrane domains, particularly in the central portion of the sequence. The protein appears to have characteristic features of membrane proteins, with hydrophobic stretches that could span the bacterial cell membrane. While the exact function remains uncharacterized, its amino acid composition and predicted topology suggest potential involvement in membrane transport or signaling processes .

To determine potential function, researchers should employ multiple complementary approaches:

  • Sequence homology analysis using tools like BLAST against well-characterized proteins

  • Secondary structure prediction using algorithms like PSIPRED

  • Transmembrane topology prediction using TMHMM or MEMSAT

  • Structural modeling using comparative modeling or ab initio approaches

  • Gene neighborhood analysis to identify functional associations

How can HI_0485.1 be efficiently expressed in recombinant systems?

The successful recombinant expression of HI_0485.1 requires careful consideration of expression systems and conditions. Current protocols demonstrate effective expression in E. coli with an N-terminal His-tag . The following methodological approach is recommended:

  • Vector selection: pET-based vectors with T7 promoter systems offer strong inducible expression

  • Host strain optimization: BL21(DE3) derivatives are recommended, particularly C41(DE3) or C43(DE3) for membrane proteins

  • Induction conditions: Use lower temperatures (16-25°C) and reduced IPTG concentrations (0.1-0.5 mM) to prevent inclusion body formation

  • Extraction protocol: Employ mild detergents (DDM, LDAO) for membrane protein solubilization

Expression yields can be enhanced by codon optimization for E. coli, as H. influenzae has different codon usage patterns. For difficult-to-express proteins, consider fusion partners such as MBP or SUMO to improve solubility and folding .

What purification strategies are most effective for HI_0485.1?

Given its predicted membrane protein characteristics and the availability of His-tagged recombinant versions, a multi-step purification strategy is recommended:

Purification StepTechniqueBuffer ConditionsExpected Results
Initial CaptureNi-NTA Affinity20 mM Tris pH 8.0, 300 mM NaCl, 0.05% DDM, 20-250 mM imidazole gradient>80% purity
IntermediateSize Exclusion20 mM Tris pH 7.5, 150 mM NaCl, 0.03% DDM>90% purity, removal of aggregates
Polishing (optional)Ion Exchange20 mM HEPES pH 7.0, 50-500 mM NaCl gradient, 0.03% DDM>95% purity

For membrane proteins like HI_0485.1, maintaining detergent concentrations above the critical micelle concentration throughout all purification steps is essential to prevent protein aggregation. SDS-PAGE analysis should confirm purity greater than 90% as reported for commercial preparations .

How can structural characterization of HI_0485.1 be approached given its uncharacterized nature?

Structural characterization of uncharacterized membrane proteins presents significant challenges. A systematic approach combining multiple techniques is recommended:

  • Secondary structure analysis:

    • Circular Dichroism (CD) spectroscopy in detergent micelles or reconstituted liposomes

    • FTIR spectroscopy to quantify α-helical and β-sheet content

  • Tertiary structure investigation:

    • Small-angle X-ray scattering (SAXS) for low-resolution envelope structure

    • Nuclear Magnetic Resonance (NMR) spectroscopy for proteins <30 kDa in size

    • X-ray crystallography following detergent screening and crystal optimization

    • Cryo-electron microscopy for larger complexes

  • Dynamics and interactions:

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS)

    • Fluorescence resonance energy transfer (FRET) with strategically placed fluorophores

For membrane proteins like HI_0485.1, lipid nanodiscs or amphipols may provide better environments for structural studies than traditional detergent micelles. Given the challenges in membrane protein structure determination, integrative structural biology approaches combining multiple data sources with computational modeling are particularly valuable .

How might HI_0485.1 contribute to Haemophilus influenzae pathogenesis?

While direct evidence for HI_0485.1's role in pathogenesis is currently lacking, several hypotheses can be formulated based on its characteristics and the known pathogenesis mechanisms of H. influenzae:

  • Immune evasion: Similar to the identified Protein H (PH) in H. influenzae, HI_0485.1 might interact with host immune components. PH binds factor H, helping bacteria resist complement activation . HI_0485.1 could potentially interact with other immune regulators.

  • Adhesion or invasion: The membrane-spanning properties suggest possible involvement in adhesion to host cells or tissues.

  • Nutrient acquisition: Many bacterial membrane proteins facilitate uptake of essential nutrients from the host environment.

To investigate these possibilities, researchers should consider:

  • Gene knockout studies to assess virulence in infection models

  • Protein-protein interaction studies with host factors

  • Localization studies during infection

  • Transcriptomic analysis to identify expression patterns during different infection stages

What statistical experimental design is appropriate for functional characterization of HI_0485.1?

Functional characterization of an uncharacterized protein requires robust experimental design. Following established statistical experimental design principles , researchers should consider:

  • Research question formulation: Clearly define testable hypotheses about HI_0485.1 function

  • Variable identification:

    • Independent variables: experimental conditions (e.g., expression levels, mutations)

    • Dependent variables: measurable outcomes (e.g., binding affinity, growth phenotypes)

    • Control variables: factors kept constant across experiments

  • Experimental groups:

    • Treatment group: expressing or overexpressing HI_0485.1

    • Control group: null mutant or vector-only controls

    • Reference groups: known related proteins for comparative analysis

  • Sampling and replication:

    • Technical replicates: minimum 3 per condition

    • Biological replicates: independent bacterial cultures/transformations

  • Randomization and blinding:

    • Randomize sample processing order

    • Blind analysts to sample identity when applicable

For example, when investigating potential interactions with host factors, a factorial design might include multiple protein concentrations, various host factors, and different pH conditions, systematically testing all combinations to identify significant interactions and effects .

What proteomic approaches would be most informative for studying HI_0485.1 in its native context?

Proteomic characterization of HI_0485.1 in its native context requires specialized approaches for membrane proteins:

  • Expression verification:

    • Targeted proteomics using selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

    • Western blotting with antibodies against epitope tags or the native protein

  • Interaction partners identification:

    • Proximity labeling (BioID or APEX) fused to HI_0485.1

    • Co-immunoprecipitation with crosslinking for transient interactions

    • Blue native PAGE for intact membrane protein complexes

  • Localization and dynamics:

    • Fractionation-based proteomics comparing membrane vs. cytosolic fractions

    • Dynamic SILAC to measure protein turnover rates

    • Cell-surface biotinylation to confirm surface exposure

  • Post-translational modifications:

    • Phosphoproteomics to identify regulatory modifications

    • Glycoproteomics to identify potential glycosylation sites

Sample preparation should include specialized methods for membrane proteins, such as phase partitioning or specialized detergents. Mass spectrometric analysis should employ techniques optimized for hydrophobic peptides, including alternative proteases to trypsin (such as chymotrypsin or elastase) for improved sequence coverage .

How can gene expression systems be optimized to study the regulation of HI_0485.1?

Understanding the regulation of HI_0485.1 expression requires sophisticated gene expression systems. Recommended approaches include:

  • Promoter analysis:

    • Reporter gene fusion (luciferase, GFP) to the native promoter

    • Deletion analysis to identify regulatory elements

    • ChIP-seq to identify transcription factor binding sites

  • Expression conditions:

    • RNA-seq under various environmental conditions (pH, oxygen, nutrients)

    • qRT-PCR to quantify expression during different growth phases

    • In vivo expression technology (IVET) to identify host-induced expression

  • Regulatory network mapping:

    • Transcriptional regulator overexpression or deletion library screening

    • CRISPR interference for targeted repression of potential regulators

    • Ribosome profiling to assess translational regulation

For example, to study environmental regulation, a systematic approach would include exposure to different conditions followed by expression analysis:

ConditionMethodExpected OutcomeControl
pH variationqRT-PCR, RNA-seqExpression changes at different pH valuesHousekeeping genes
Nutrient limitationReporter fusionsIdentification of inducing conditionsConstitutive promoter
Host factorsEx vivo infection modelsHost-induced expression patternsIn vitro growth
Oxygen levelsAnaerobic vs. aerobic cultureOxygen-dependent regulationKnown oxygen-regulated genes

How should contradictory functional predictions for HI_0485.1 be resolved?

In silico functional predictions for uncharacterized proteins often yield contradictory results. To resolve such contradictions:

  • Evaluate prediction confidence:

    • Assess statistical confidence scores from each prediction method

    • Consider evolutionary conservation as a measure of functional importance

    • Weigh predictions from experimentally validated homologs more heavily

  • Integrate multiple evidence types:

    • Combine sequence-based, structure-based, and genomic context predictions

    • Use weighted voting schemes based on method accuracy for similar proteins

    • Apply Bayesian integration of multiple prediction scores

  • Design discriminatory experiments:

    • Identify experiments that can distinguish between competing functional hypotheses

    • Prioritize direct functional assays over indirect or correlative evidence

    • Use CRISPR-based screens to test multiple functional hypotheses simultaneously

  • Apply hierarchical validation:

    • Start with broad functional class validation

    • Progress to specific biochemical activity testing

    • Confirm physiological relevance in cellular context

When faced with contradictory predictions, researchers should avoid confirmation bias by designing experiments that could disprove, rather than only support, their favored hypothesis .

What computational approaches can predict interaction partners for HI_0485.1?

Predicting protein-protein interactions for uncharacterized proteins requires sophisticated computational approaches:

  • Sequence-based methods:

    • Interolog mapping based on interactions of homologous proteins

    • Co-evolution analysis to identify correlated mutations in potentially interacting proteins

    • Interface prediction from amino acid composition and hydrophobicity patterns

  • Structure-based approaches:

    • Molecular docking if structural models are available

    • Template-based interaction site prediction

    • Electrostatic complementarity analysis

  • Genomic context methods:

    • Gene neighborhood analysis in the H. influenzae genome

    • Phylogenetic profiling to identify proteins with similar evolutionary patterns

    • Gene fusion detection in related species

  • Network-based predictions:

    • Guilt-by-association in protein interaction networks

    • Pathway enrichment analysis

    • Random walk with restart on heterogeneous networks

Verification of predicted interactions should employ orthogonal experimental methods such as yeast two-hybrid, pull-down assays, or cross-linking mass spectrometry. Given the membrane localization of HI_0485.1, specialized techniques like membrane yeast two-hybrid or split-ubiquitin systems may be necessary .

How can CRISPR-Cas systems be applied to study HI_0485.1 function in Haemophilus influenzae?

CRISPR-Cas systems offer powerful approaches for genetic manipulation of bacterial systems, including for studying uncharacterized proteins like HI_0485.1:

  • Gene knockout studies:

    • CRISPR-Cas9 for precise gene deletion

    • Phenotypic characterization under various conditions

    • Competitive fitness assays in mixed infections

  • CRISPRi for gene repression:

    • dCas9-based transcriptional repression for essential genes

    • Titrable repression using inducible promoters

    • Multiplex targeting of redundant genes

  • CRISPRa for overexpression:

    • dCas9-activator fusion for enhanced expression

    • Study of dose-dependent phenotypes

    • Synthetic genetic interaction mapping

  • Base editing and prime editing:

    • Introduction of point mutations without double-strand breaks

    • Structure-function analysis through systematic mutagenesis

    • Regulatory element manipulation

While H. influenzae transformation efficiency can be challenging, optimization strategies include:

  • Use of MIV (M-IV) competence induction medium

  • Delivery of CRISPR components on shuttle vectors

  • Conjugation-based transfer from E. coli

Combined with high-throughput phenotypic screening, CRISPR-based approaches can rapidly advance understanding of HI_0485.1 function in its native context .

What role might HI_0485.1 play in antibiotic resistance or susceptibility?

The potential role of HI_0485.1 in antibiotic resistance merits investigation, particularly given its predicted membrane localization:

  • Hypothetical mechanisms:

    • Efflux pump component or regulator

    • Membrane permeability modulator

    • Stress response element affecting antibiotic tolerance

    • Target modification enzyme protector

  • Experimental approaches:

    • Minimum inhibitory concentration (MIC) determination in knockout/overexpression strains

    • Transcriptional response to antibiotic exposure

    • Antibiotic uptake and accumulation studies

    • Membrane integrity assessments

  • Potential clinical relevance:

    • Correlation of expression levels with clinical resistance patterns

    • Identification of mutations in treatment failures

    • Assessment as a potential antibiotic adjuvant target

Given the increasing prevalence of antibiotic-resistant H. influenzae, understanding the contribution of uncharacterized proteins to resistance mechanisms has significant clinical implications. A comprehensive approach would test multiple antibiotic classes against genetically modified strains with altered HI_0485.1 expression .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.